Close

Legal

Since the early 1970s, Dr. Peter Breggin has been active as a medical expert in malpractice and product liability suits, as well as criminal cases in which psychiatric or psychoactive drugs have contributed to abnormal behavior. He has also testified in cases involving involuntary treatment, electroshock treatment, and psychosurgery. He has testified more than 70 times in court.

In the 1990s, Dr. Breggin was chosen to be the medical and scientific expert for nearly 200 combined Prozac product liability suits against Eli Lilly and Company. This resulted in his testifying in the infamous Wesbecker case in which the manufacturer, Eli Lilly, fixed the trial. Link. Later Dr. Breggin would become an expert in many other product liability suits involving antidepressants, stimulants, tranquilizers and antipsychotic drugs, nearly all of which were settled. As an expert in these product liability suits, the courts have empowered Dr. Breggin to examine secret company records concerning the development and marketing of their drugs. This unique experience of looking inside otherwise hidden drug company files has provided him a unique source of information and a special understanding of drug company activities that he has used in his legal work and documented in many publications, including Brain-Disabling Treatments in Psychiatry (2008) and Medication Madness (2008).

Among his proudest achievements, in the early 1970s Dr. Breggin was the medical expert in the famous Kaimowitz case that stopped lobotomy and psychosurgery in America’s state mental hospitals. LINK More recently he was the psychiatric expert in a psychosurgery case against the Cleveland Clinic that resulted in a huge verdict for the injured woman and caused the clinic to stop doing any further psychosurgery. LINK Dr. Breggin was also the medical expert in the only electroshock malpractice suit to be won by the plaintiffs. LINK.

Some of Dr. Breggin’s most successful legal work has involved testimony in tardive dyskinesia malpractice suits involving this usually irreversible abnormal movement disorder commonly caused by antipsychotic or neuroleptic drugs. In all but one of the many TD trials in which he has participated in the United States and Canada, the injured patient has won a favorable verdict. The one exception ended in a hung jury. He has also been involved in tardive dyskinesia cases with multi-million dollar settlements without going to trial in both the United States and Canada.

Dr. Breggin continues with both his clinical practice and his medical expert work.

Jury Awards $1.5 million for suicide involving antidepressants based on Dr. Breggin’s testimony

A Syracuse, N.Y. jury has awarded a $1.5 million medical malpractice verdict to the family of a man who committed suicide. I was the medical expert for the family. After the verdict, plaintiff’s attorney Ernest DelDuchetto told me, “It was comforting to see a jury agree with our proposition that these drugs (antidepressants) are not panaceas for all sadness,” and that they can have serious harmful effects.

Read More

Antidepressant-induced suicidality and violence: more about deception than science

Report Presented at the September 14, 2004 Press Conference Sponsored by the Alliance for Human Research Protection (AHRP) at the FDA Public Hearing on Antidepressants and Suicide. Antidepressant-Induced Suicidality and Violence: More About Deception than Science Observations Made at the FDA Hearings Press Conference, September 14, 2004 By Peter R. Breggin, M.D. The FDA is […]

Read More

The Proven Dangers of Antidepressants

by Peter R. Breggin, M.D. On March 22 the FDA issued an extraordinary “Public Health Advisory” that cautioned about the risks associated with the whole new generation of antidepressants including Prozac and its knock offs, Zoloft, Paxil, Luvox, Celexa, and Lexapro, as well as Wellbutrin, Effexor, Serzone, and Remeron. The warning followed a public hearing […]

Read More

FDA Issues Public Health Advisory on Cautions for Use of Antidepressants in Adults and Children

The Food and Drug Administration today issued a Public Health Advisory that provides further cautions to physicians, their patients, and families and caregivers of patients about the need to closely monitor both adults and children with depression, especially at the beginning of treatment, or when the doses are changed with either an increase or decrease […]

Read More

The FDA Continues to Affirm Antidepressant Risks First Identified in my 1991 Book Toxic Psychiatry By Peter R. Breggin, M.D. Ithaca, New York www.breggin.com   In 2004 the FDA issued a black box warning about the increased risk of suicidality in children taking the newer antidepressants, including the SSRIs (Prozac, Zoloft, Paxil, Luvox, Celexa, and […]

Read More

The Landmark Kaimowitz Trial Against Psychosurgery

THREE-JUDGE OPINION ULTIMATELY ENDS PSYCHOSURGERY IN STATE HOSPITALS, VA AND NIH DR. BREGGIN’S TESTIMONY SETS STAGE TO INVOKE NUREMBERG CODE   The following is excerpted and slightly revised from a longer article by Dr. Breggin on the history of his reform work in stopping the return of lobotomy and psychosurgery in the 1970s and then in […]

Read More

Suppressed Paxil suicide data released

Suppressed Paxil Suicide Data Released Expert Calls for Drug Companies to Publish Safety and Efficacy Data February 27, 2006, Ithaca, New York   Ethical Human Psychology and Psychiatry (EHPP) has published an excerpt from a previously sealed product liability report against Glaxo SmithKline (GSK). The medical expert report documents how the company systematically hid and […]

Read More

Paxil suicide product liability case resolved

Paxil Product Liability Suit Resolved   A man with no previous history of violence or suicide drowned himself and his two children in a bathtub after taking two doses of Paxil. Paxil is an antidepressant of the SSRI (selective serotonin reuptake inhibitor) class, which also includes Prozac, Zoloft, Celexa and Luvox.   Psychiatrist Peter R. […]

Read More

Lacuzong v. GlaxoSmithKline

Lacuzong product liability case against GlaxoSmithKline (makers of Paxil®) The suit Lacuzong v. GlaxoSmithKline (GSK) was brought by the widow of a man who drowned their two children and himself in a tub after taking Paxil for three days. The case was “resolved” to the satisfaction of the family; the drug company denied and continues […]

Read More